New senior executives named at Sanofi; former EFPIA DG Nelly Baudrihaye has died

23 July 2011

French drug major  Sanofi (Euronext: SAN) on Friday announced the appointment of Greg Irace, currently president and chief executive of Sanofi's US operations, to the newly created role of senior vice president, Global Services.

In his new role, Mr Irace will lead the global information systems function, be responsible for shared support functions across all Sanofi businesses in North America and play a key role in the development of a global strategy for shared services. He will report to Jerome Contamine, executive vice president, chief financial officer, and will continue to be a member of the global management Committee. He will be based in Bridgewater, New Jersey.

Additionally, Anne Whitaker will join Sanofi as president, North America, Pharmaceuticals, effective September 1, 2011. She will report to Hanspeter Spek, president, global operations and will join the global management committee. She will be based in Bridgewater, New Jersey. Ms Whitaker joins Sanofi from GlaxoSmithKline, where she was senior vice president and business unit head, Cardiovascular, Metabolic and Urology, since 2009.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical